Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 83 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8471040

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  2. US 8470837

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  3. US 8471014

    Process of making gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  4. US 8466288

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  5. US 8466290

    STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient

    Pharmadesign, Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  6. US 8461149

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  7. US 8461163

    Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1

    Takeda Pharmaceutical Company Limited · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  8. US 8455652

    Inhibitors for the soluble epoxide hydrolase

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  9. US 8455688

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  10. US 8455653

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  11. US 8455507

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  12. US 8454977

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  13. US 8455621

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  14. US 8455497

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  15. US 8455493

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  16. US 8450489

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2013 · Expires May 23, 2033

    granted

  17. US 8450341

    Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  18. US 8450532

    Compounds useful in the preparation of tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  19. US 8449890

    Neprilysin inhibitors

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  20. US 8450321

    6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    GILEAD CONNECTICUT, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  21. US 8450332

    LIMK2 inhibitors, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  22. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2013 · Expires May 16, 2033

    granted

  23. US 8445491

    Wnt protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted May 21, 2013 · Expires May 16, 2033

    granted

  24. US 8440667

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.